Academic staff at Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Education, Third Faculty of Medicine
Publications
- Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma2025 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Cancer Immunology, Immunotherapy Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)2025 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Clinical & Experimental Metastasis Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study2025 | Faculty of Medicine in Pilsen
- Scientific Reports Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab2025 | Faculty of Medicine in Pilsen
- Klinická onkologie Ivosidenib v léčbě metastatického cholangiocelulárního karcinomu - kazuistika2025 | Faculty of Medicine in Hradec Králové
- Onkologická revue Co přináší nivolumab pacientům s nádory močového měchýře2025 | Faculty of Medicine in Hradec Králové
- Onkologická revue Cemiplimab v léčbě pacienta s neoperabilním pokročilým spinocelulárním karcinomem - kazuistika2025 | Faculty of Medicine in Hradec Králové
- Onkologie Současné možnosti adjuvantní léčby uroteliálních karcinomů2025 | Publication without faculty affiliation
- Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...
